Radiopharmaceutical merger must be further reviewed in Brazil, CADE Councilor Fernandes says
A planned radiopharmaceutical merger between GSH Corp Participações and R2 IBF Participações must be further scrutinized by the Brazilian competition authority, said agency Councilor Victor Fernandes, citing concerns about insufficient competition...To view the full article, register now.
Already a subscriber? Click here to view full article